Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001096906-23-002096
Filing Date
2023-11-06
Accepted
2023-11-06 12:13:32
Documents
62
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 10-K/A SEC FILING tpia-20221231.htm   iXBRL 10-K/A 500630
  Complete submission text file 0001096906-23-002096.txt   3248573

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpia-20221231_cal.xml EX-101.CAL 19991
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20221231_def.xml EX-101.DEF 81784
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20221231_lab.xml EX-101.LAB 186815
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20221231_pre.xml EX-101.PRE 168889
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20221231.xsd EX-101.SCH 39020
56 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20221231_htm.xml XML 474804
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-56022 | Film No.: 231379125
SIC: 2833 Medicinal Chemicals & Botanical Products